Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · IEX Real-Time Price · USD
43.76
+2.78 (6.78%)
May 3, 2024, 4:00 PM EDT - Market closed
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 226 employees on December 31, 2023. The number of employees increased by 49 or 27.68% compared to the previous year.
Employees
226
Change (1Y)
49
Growth (1Y)
27.68%
Revenue / Employee
$342,602
Profits / Employee
-$817,159
Market Cap
2.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 226 | 49 | 27.68% |
Dec 31, 2022 | 177 | 37 | 26.43% |
Dec 31, 2021 | 140 | 50 | 55.56% |
Dec 31, 2020 | 90 | 20 | 28.57% |
Dec 31, 2019 | 70 | 16 | 29.63% |
Dec 31, 2018 | 54 | 28 | 107.69% |
Dec 31, 2017 | 26 | 11 | 73.33% |
Dec 31, 2016 | 15 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
LifeStance Health Group | 9,325 |
Premier | 2,800 |
Tandem Diabetes Care | 2,400 |
Indivior | 1,164 |
PTC Therapeutics | 995 |
Corcept Therapeutics | 352 |
Celldex Therapeutics | 160 |
RYTM News
- 3 days ago - Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology - GlobeNewsWire
- 9 days ago - Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - GlobeNewsWire
- 17 days ago - Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing - GlobeNewsWire
- 5 weeks ago - Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update - GlobeNewsWire